ES | RU | EN
Logo Vascular Barcelona

Bibliografía

Bibliografía

BIBLIOGRAFÍA GENERAL

  • Bergan JJ & Shortell C. “Venous Ulcers”, 22.
  • Cabrera J. et al Elargissement des Limites de la Sclerotherapie: Nouveaux Produits SclerosantsPhlebologie 1997, 50, 2, 181-188.
  • Cabrera J. et al. “Escleroterapia en microespuma: Nuevo concepto en escleroterapia. Resultados a largo plazo”. Revista Panamericana de Flebologia y Linfologia 34, Septiembre 1999; 29-37.
  • Cabrera J. et al. “Nuevo Método de Esclerosis en las Varices Tronculares. Patología Vascular” 1995; vol 1, nº 4, Octubre 1995; 55-71.
  • Cabrera J. et al, “Sclerosants in microfoam. A new approach in angiology” International Angiology, Year 2001 - Vol. 20 - N. 04 - December - pag. 322.
  • Cabrera J. et al. “Treatment of Varicose Long Saphenous Veins with Sclerosants in Microfoam Form: Long-Term Outcomes”. Phlebology (2000) 15; 19-23.
  • Cabrera J. et al. “Treatment of Venous Malformations with Sclerosant in Microfoam Form” Arch Dermatol. Vol 139, Nov 2003.
  • Cabrera J. et al. “Ultrasound-Guided Injection of Polidocanol Microfoam in the Management of Venous Leg Ulcers” Editorial y Portada. Arch Dermatol. Vol 140, June 2004.
  • Coleridge Smith P. chronic venous disease treated by ultrasound guided Foam sclerotherapy. Eur J Vasc Endovasc Surg 2006; 32:577-83.
  • Coleridge Smith P. Echo-guided sclerotherapy: the future?. Phlebology Digest.3; Vol 19. 2006. 4-6.
  • Coleridge Smith P. Saphenous ablation: sclerosant or sclerofoam?. Semin Vasc Surg. 2005 Mar; 18(1):19-24.
  • Guex JJ, Allaert FA, GilletJL, et al. Inmediate and midterm complications of sclerotherapy: report of a prospective multicentre registry of 12,173 sclerotherapy sessions. Dermatol Surg. 2005; 31:123-8.
  • Hamel-Desnos C, Desnos P, Wollman JC, et al . Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphanous vein: initial results. Dermatol Surg 2003; 29:1170-5.
  • Ouvry P.,Allaert F., Desnos P, Hamel- Desnos C. Efficay of Polidocanol Foam versus liquid in sclerotherapy Of. the great saphenous vein: A multicentre Randomised Controlled Trial with 2-year follow-up. Eur J Vasc Endovasc Surg. 2008. 36, 366-370.
  • Schadeck M, Allaert FA. Duplex scanning in the mechanism of the sclerotherapy: importance of the spasm. Phlebology 1995; Suppl1:574-576.
  • SchadeckM, Allaert FA. Echo-sclerose de la grande saphene. Phlebologie 1993; 46,673-82.
  • Tessari L, Cavezzi A, Frullini A, Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg 2001 Jan; 27(1):58-60.
  • Tessari L. Nouvelle technique d´obtention de la sclero-mousee. Phlébologie 2000; 53(1):129.
  • Van den Bos R et al. Endovenous therapies of lower extremity varicosites. A meta-analysis. J Vasc Surg 2009 Jan; 49(1):230-9.

MÉTODOS DE FABRICACIÓN DE ESPUMAS ESCLEROSANTES

  • Jan-Christoph GR Wollmann. Foam Sclerotherapy. John Bergan, Van Le Cheng. Pag. 8. Royal society of medicine Press Ltd. 2008.
  • John Bergan, Van Le Cheng. 2008. Foam sclerotherapy. A textbook. Royal Society of Medicine.
  • JP. Gobin JP. Benigni, La sclerotherapie et maladie veineuse chronique superficielle. Editions Eska, 2007.
  • Varios Autores, Foam sclerotherapy. State of the art. Ed. J.P Henriet. Editiones Phlebologiques Francaises, 2002.

ESTUDIOS DE SEGURIDAD

  • Foam Sclerotherapy. John Bergan, Van Le Cheng. Pag. 183-193. Royal society of medicine Press Ltd. 2008.
  • Guex JJ, Allaert FA, GilletJL, et al. Inmediate and midterm complications of sclerotherapy: report of a prospective multicentre registry of 12, 173 sclerotherapy sessions. Dermatol Surg. 2005; 31:123-8.
  • Nick Morrison. Comparisons of side effects using air and carbon dioxide foam for endovenous chemical ablation J Vasc Surg. 2008 Jan 31.
  • Nick Morrison. Studies on safety of foam sclerotherapy.

CONSENSO INTERNACIONAL

  • Breu F.X., Guggenbichler. European Consensus Meeting on Foam Sclerotherapy. Tegernsee Germany VASA 2008.
  • Breu F.X., Guggenbichler S. European Consensus Meeting on Foam Sclerotherapy. Apryl 4-6, 2003, Tegernsee Germany, Dermatol Surg 2004; 30:709-717.
CLÍNICA VASCULAR Barcelona. Oliana, 27 08006 Barcelona · Tel. 93 209 90 23· info@vascularbarcelona.com · Condiciones de uso | © 2011 TANDA